Literature DB >> 7007066

Fractionated total body irradiation and autologous bone marrow transplantation in dogs: hemopoietic recovery after various marrow cell doses.

U Bodenberger, H J Kolb, I Rieder, B Netzel, E Schäffer, H Kolb, S Thierfelder.   

Abstract

Hemopoietic recovery was studied in dogs given 2400 R fractionated total body irradiation within one week and graded doses of cryopreserved autologous bone marrow. Complete hemopoietic recovery including histology was observed after this dose and sufficient doses of marrow cells. Doses of more than 5.5 X 10(7) mononuclear marrow cells/kg body weight were sufficient for complete recovery in all dogs, 1.5 to 5.5 X 10(7) cells/kg were effective in some of the dogs and less than 1.5 X 10(7) cells/kg were insufficient for complete recovery. Similarly, more than 30,000 CFUc/kg body weight were required for hemopoietic recovery. The optimal marrow cells dose which has been defined as the minimal dose required for the earliest possible recovery of leukocyte and platelet counts was 7-8 X 10(7) mononuclear marrow cells/kg body weight. It has been concluded that fractionated total body irradiation with 2400 R does not require greater doses of marrow cells for hemopoietic reconstitution than lower single doses and that the hemopoietic microenvironment is not persistently disturbed after this dose.

Entities:  

Mesh:

Year:  1980        PMID: 7007066

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  10 in total

Review 1.  The hematopoietic system in the context of regenerative medicine.

Authors:  Christopher D Porada; Anthony J Atala; Graça Almeida-Porada
Journal:  Methods       Date:  2015-08-28       Impact factor: 3.608

Review 2.  Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?

Authors:  Kristy L Richards; Steven E Suter
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

3.  Biopterin level in blood cells as a marker for hemopoietic cell proliferation during autologous bone marrow transplantation in beagle dogs.

Authors:  I Ziegler; H J Kolb; U Bodenberger; W Wilmanns
Journal:  Blut       Date:  1982-05

4.  Clinical and pathological findings in dogs following supralethal total body irradiation with and without infusion of autologous long-term marrow culture cells.

Authors:  A C Abrams-Ogg; S A Kruth; R F Carter; J E Dick; V E Valli; S Kamel-Reid; I D Dubé
Journal:  Can J Vet Res       Date:  1993-04       Impact factor: 1.310

5.  Bone marrow cell dose and kinetics of recovery following allogeneic marrow transplantation in man.

Authors:  D Niederwieser; A Gratwohl; M Oberholzer; B Osterwalder; C Nissen; B Speck
Journal:  Blut       Date:  1983-12

Review 6.  Marrow graft studies in dogs: factors influencing resistance to engraftment and graft-versus-host disease.

Authors:  H J Deeg; R Storb; E D Thomas
Journal:  Surv Immunol Res       Date:  1982

7.  Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.

Authors:  M Lupu; R Storb
Journal:  Vet Comp Oncol       Date:  2007-03       Impact factor: 2.613

8.  Animal Models for Preclinical Development of Allogeneic Hematopoietic Cell Transplantation.

Authors:  Scott S Graves; Maura H Parker; Rainer Storb
Journal:  ILAR J       Date:  2018-12-31

9.  [Adriamycin and autologous bone marrow transplantation. Preclinical studies in dogs (author's transl)].

Authors:  U Bodenberger; H J Kolb; L Böning; H Sauer; E Holler; B Höfling; R Pelka-Fleischer; W Wilmanns
Journal:  Blut       Date:  1982-02

Review 10.  Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.

Authors:  Scott S Graves; Rainer Storb
Journal:  Vet Med Sci       Date:  2021-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.